Founder & COO, CTPharma
Rino Ferrarese is the president, COO and co-founder of CTPharma, a biotech company with clinical stage and discovery assets derived from cannabis. In 2019, CTPharma announced its FDA-approved IND trial in collaboration with Yale School of Medicine.
Rino has spent his career working in FDA-regulated industries for pharmaceuticals, cosmetics and homeopathic products. Mr. Ferrarese speaks nationally on topics related to cannabis and co-authors columns for the Cannabis Business Times.